Superworth

Kiora Pharmaceuticals EPS KPRX

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
−$2.47
Latest quarter, Q2 FY26
−$0.34
Fiscal year 2025
−$2.61
−333% on the year before

Kiora Pharmaceuticals' earnings per share was −$2.47 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.34.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.61−333%
FY2024$1.12n/a
FY2023−$26.17n/a
FY2022−$236.43n/a
FY2021−$559.26n/a
FY2020−$633.60n/a
FY2019−$831.60n/a
FY2018−$1836.00n/a
FY2017−$5184.00n/a
FY2016−$8154.00n/a
FY2015−$21654.00n/a
FY2014−$25812.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.34n/a−$2.47
Q1 FY26−$0.58n/a−$2.67
Q4 FY25−$1.56n/a−$2.61
Q3 FY25$0.01n/a−$2.05
Q2 FY25−$0.54n/a−$2.87
Q1 FY25−$0.52−115%−$2.86
Q4 FY24−$1.00n/a$1.12
Q3 FY24−$0.81n/a−$0.60
Q2 FY24−$0.53n/a−$7.09
Q1 FY24$3.46n/a−$13.71
Q4 FY23−$2.72n/a−$26.17
Q3 FY23−$7.30n/a−$39.38

Against its peers

Companies in Drug Manufacturers - General nearest Kiora Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
KPRXKiora Pharmaceuticals−$2.47
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Kiora Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.